ConocoPhillips a un objectif de cours consensuel de $116.89 basé sur les évaluations de 20 analystes. Le plus élevé est $139, publié par Truist Securities le janvier 13, 2025. Le plus bas est $100, publié par Wells Fargo le octobre 17, 2025. Les 3 évaluations d’analystes les plus récentes ont été publiées par UBS, Susquehanna et Wells Fargo le novembre 12, 2025, octobre 20, 2025 et octobre 17, 2025, respectivement. Avec un objectif de cours moyen de $109 entre UBS, Susquehanna et Wells Fargo, il existe une variation implicite de 21.44% upside pour ConocoPhillips selon ces dernières évaluations d’analystes.
1calculé à partir des notes des analystes
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/12/2025 | 30.35% | UBS | $122 → $117 | Maintains | Buy | |||
10/20/2025 | 22.56% | Susquehanna | $113 → $110 | Maintains | Positive | |||
10/17/2025 | 11.41% | Wells Fargo | → $100 | Initiates | → Equal-Weight | |||
10/14/2025 | 35.93% | Morgan Stanley | $123 → $122 | Maintains | Overweight | |||
10/13/2025 | 31.47% | RBC Capital | $113 → $118 | Maintains | Outperform | |||
10/07/2025 | 31.47% | Barclays | $122 → $118 | Maintains | Overweight | |||
10/06/2025 | 23.67% | Evercore ISI Group | $115 → $111 | Maintains | Outperform | |||
09/15/2025 | 33.7% | Mizuho | $125 → $120 | Maintains | Outperform | |||
09/08/2025 | 28.13% | Raymond James | $117 → $115 | Maintains | Outperform | |||
08/20/2025 | 38.15% | UBS | $116 → $124 | Maintains | Buy | |||
08/20/2025 | 30.35% | Melius Research | → $117 | Initiates | → Hold | |||
08/18/2025 | 38.15% | Piper Sandler | $123 → $124 | Maintains | Overweight | |||
08/11/2025 | 29.24% | UBS | $115 → $116 | Maintains | Buy | |||
08/11/2025 | 37.04% | Morgan Stanley | $119 → $123 | Maintains | Overweight | |||
07/23/2025 | 25.9% | Susquehanna | $114 → $113 | Maintains | Positive | |||
07/22/2025 | 30.35% | Raymond James | $109 → $117 | Maintains | Outperform | |||
07/15/2025 | 37.04% | Piper Sandler | $113 → $123 | Maintains | Overweight | |||
07/11/2025 | 28.13% | UBS | $111 → $115 | Maintains | Buy | |||
07/11/2025 | 11.41% | Scotiabank | $95 → $100 | Maintains | Sector Perform | |||
07/11/2025 | 25.9% | RBC Capital | $115 → $113 | Maintains | Outperform | |||
07/02/2025 | 25.9% | Piper Sandler | $107 → $113 | Maintains | Overweight | |||
06/26/2025 | 30.35% | Wells Fargo | $113 → $117 | Maintains | Overweight | |||
06/11/2025 | 28.13% | Citigroup | $140 → $115 | Maintains | Buy | |||
05/30/2025 | 28.13% | RBC Capital | $120 → $115 | Maintains | Outperform | |||
05/23/2025 | 18.1% | B of A Securities | $107 → $106 | Maintains | Neutral | |||
05/20/2025 | 21.44% | Raymond James | $103 → $109 | Maintains | Outperform | |||
05/14/2025 | 25.9% | Wells Fargo | $116 → $113 | Maintains | Overweight | |||
05/13/2025 | 19.21% | Piper Sandler | $114 → $107 | Maintains | Overweight | |||
05/13/2025 | 39.27% | Mizuho | $127 → $125 | Maintains | Outperform | |||
05/12/2025 | 27.01% | Susquehanna | $120 → $114 | Maintains | Positive | |||
05/09/2025 | 31.47% | Morgan Stanley | $116 → $118 | Maintains | Overweight | |||
04/29/2025 | 19.21% | B of A Securities | $138 → $107 | Downgrade | Buy → Neutral | |||
04/23/2025 | 33.7% | Barclays | $135 → $120 | Maintains | Overweight | |||
04/22/2025 | 33.7% | Susquehanna | $128 → $120 | Maintains | Positive | |||
04/16/2025 | 41.5% | Mizuho | $134 → $127 | Maintains | Outperform | |||
04/15/2025 | 23.67% | UBS | $116 → $111 | Maintains | Buy | |||
04/15/2025 | 29.24% | Wells Fargo | $131 → $116 | Maintains | Overweight | |||
04/14/2025 | 33.7% | RBC Capital | $133 → $120 | Maintains | Outperform | |||
04/11/2025 | 5.84% | Scotiabank | $115 → $95 | Maintains | Sector Perform | |||
04/07/2025 | 29.24% | UBS | $130 → $116 | Maintains | Buy | |||
03/27/2025 | 40.38% | Morgan Stanley | $131 → $126 | Maintains | Overweight | |||
03/13/2025 | 28.13% | JP Morgan | $127 → $115 | Maintains | Overweight | |||
02/12/2025 | 52.64% | UBS | $140 → $137 | Maintains | Buy | |||
02/10/2025 | 38.15% | Raymond James | $157 → $124 | Downgrade | Strong Buy → Outperform | |||
02/10/2025 | 42.61% | Wells Fargo | $132 → $128 | Maintains | Overweight | |||
02/10/2025 | 50.41% | Barclays | $137 → $135 | Maintains | Overweight | |||
01/23/2025 | 74.92% | Raymond James | $148 → $157 | Maintains | Strong Buy | |||
01/14/2025 | 47.07% | Wells Fargo | $134 → $132 | Maintains | Overweight | |||
01/13/2025 | 54.87% | Truist Securities | $138 → $139 | Maintains | Buy | |||
12/19/2024 | 27.01% | Piper Sandler | $135 → $114 | Maintains | Overweight | |||
12/16/2024 | 49.3% | Mizuho | $132 → $134 | Upgrade | Neutral → Outperform | |||
12/09/2024 | 49.3% | Wells Fargo | $131 → $134 | Maintains | Overweight | |||
12/06/2024 | 83.83% | Evercore ISI Group | → $165 | Reinstates | → Outperform | |||
12/04/2024 | 37.04% | JP Morgan | $120 → $123 | Upgrade | Neutral → Overweight | |||
11/01/2024 | 47.07% | Mizuho | $129 → $132 | Maintains | Neutral | |||
11/01/2024 | 64.89% | Susquehanna | $144 → $148 | Maintains | Positive | |||
11/01/2024 | 52.64% | Barclays | $135 → $137 | Maintains | Overweight | |||
10/18/2024 | 60.44% | Susquehanna | $147 → $144 | Maintains | Positive | |||
10/11/2024 | 40.38% | JP Morgan | $139 → $126 | Assumes | Neutral → Neutral | |||
10/10/2024 | 28.13% | Scotiabank | $120 → $115 | Maintains | Sector Perform | |||
10/04/2024 | 39.27% | BMO Capital | $123 → $125 | Maintains | Outperform | |||
10/03/2024 | 50.41% | Barclays | $156 → $135 | Maintains | Overweight | |||
09/30/2024 | 53.75% | Truist Securities | $145 → $138 | Maintains | Buy | |||
09/27/2024 | 47.07% | Wells Fargo | $150 → $132 | Maintains | Overweight | |||
09/18/2024 | 55.98% | UBS | $153 → $140 | Maintains | Buy | |||
09/16/2024 | 43.72% | Mizuho | $132 → $129 | Maintains | Neutral | |||
09/13/2024 | 55.98% | RBC Capital | $140 → $140 | Reiterates | Outperform → Outperform | |||
09/04/2024 | 63.78% | Susquehanna | $154 → $147 | Maintains | Positive | |||
08/20/2024 | 70.46% | UBS | $151 → $153 | Maintains | Buy | |||
08/06/2024 | 68.24% | UBS | $159 → $151 | Maintains | Buy | |||
08/02/2024 | 67.12% | Wells Fargo | $151 → $150 | Maintains | Overweight | |||
08/02/2024 | 61.55% | Truist Securities | $147 → $145 | Maintains | Buy | |||
07/22/2024 | 63.78% | Truist Securities | $165 → $147 | Maintains | Buy | |||
07/18/2024 | — | Wolfe Research | — | Reinstates | → Outperform | |||
07/17/2024 | 47.07% | Bernstein | $147 → $132 | Maintains | Outperform | |||
07/12/2024 | 33.7% | Scotiabank | $135 → $120 | Maintains | Sector Perform | |||
06/14/2024 | 63.78% | B of A Securities | → $147 | Reinstates | → Buy | |||
06/05/2024 | 47.07% | Mizuho | $142 → $132 | Maintains | Neutral | |||
06/03/2024 | 83.83% | Truist Securities | $160 → $165 | Maintains | Buy | |||
05/30/2024 | 78.26% | Barclays | $158 → $160 | Maintains | Overweight | |||
05/30/2024 | 77.15% | Raymond James | $155 → $159 | Reiterates | Strong Buy → Strong Buy | |||
05/15/2024 | 55.98% | RBC Capital | $135 → $140 | Maintains | Outperform | |||
05/13/2024 | 58.21% | Mizuho | $139 → $142 | Maintains | Neutral | |||
05/03/2024 | 68.24% | Wells Fargo | $149 → $151 | Maintains | Overweight | |||
04/29/2024 | 78.26% | Truist Securities | $170 → $160 | Maintains | Buy | |||
04/22/2024 | 71.58% | Susquehanna | $133 → $154 | Maintains | Positive | |||
04/18/2024 | 74.92% | Piper Sandler | $145 → $157 | Maintains | Overweight | |||
04/11/2024 | 50.41% | Scotiabank | $120 → $135 | Maintains | Sector Perform | |||
04/10/2024 | 66.01% | Wells Fargo | $141 → $149 | Maintains | Overweight | |||
04/10/2024 | 76.03% | Barclays | → $158 | Initiates | → Overweight | |||
04/05/2024 | 89.4% | Truist Securities | $173 → $170 | Maintains | Buy | |||
03/28/2024 | 43.72% | Morgan Stanley | $123 → $129 | Maintains | Overweight | |||
03/22/2024 | 54.87% | Mizuho | $132 → $139 | Reiterates | Neutral → Neutral | |||
03/14/2024 | 48.18% | Piper Sandler | $139 → $133 | Maintains | Overweight | |||
02/14/2024 | 59.32% | UBS | $138 → $143 | Maintains | Buy | |||
02/09/2024 | 33.7% | Scotiabank | $115 → $120 | Maintains | Sector Perform | |||
01/26/2024 | 48.18% | Susquehanna | $152 → $133 | Maintains | Positive | |||
01/24/2024 | 52.64% | Raymond James | $140 → $137 | Maintains | Strong Buy | |||
01/03/2024 | 47.07% | Mizuho | $139 → $132 | Maintains | Neutral | |||
12/29/2023 | 55.98% | Raymond James | $146 → $140 | Maintains | Strong Buy |
Le dernier objectif de prix pour ConocoPhillips (NYSE:COP) a été rapporté par UBS le novembre 12, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $117.00 s'attendant à ce que COP se rise dans les 12 prochains mois (un possible changement de 30.32% upside). 54 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
La dernière note d'analyste pour ConocoPhillips (NYSE:COP) a été fournie par UBS, et ConocoPhillips maintenu leur note buy.
La dernière amélioration pour ConocoPhillips a eu lieu le décembre 16, 2024 lorsque Mizuho a augmenté leur objectif de prix à $134. Mizuho avait précédemment a neutral pour ConocoPhillips.
La dernière réduction pour ConocoPhillips a eu lieu le avril 29, 2025 lorsque B of A Securities a changé leur objectif de prix de $138 à $107 pour ConocoPhillips.
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de ConocoPhillips, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour ConocoPhillips a été déposée le novembre 12, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers novembre 12, 2026.
Bien que les évaluations soient subjectives et changeront, la dernière note de ConocoPhillips (COP) était un maintenu avec un objectif de prix de $122.00 à $117.00. Le prix actuel de ConocoPhillips (COP) est de $89.78, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.